Mc2 Therapeutics Limited

Active05349119ManufacturingIncorporated 1 Feb 2005 · Guildford

The Company is a commercial stage pharmaceutical company committed to the research of skin biology and the development of novel treatment paradigms for people with auto-immune and chronic inflammatory skin conditions and the global commercialization of the Company’s drug Wynzora® Cream for the treatment of plaque psoriasis in adults.

Revenue

£18.3m

▲ +16.4% vs prior ~12m period

Profit after tax

-£221k

Margin 3.0%

Employees

8

▼ -42.9% vs prior ~12m period

Net assets

-£4.3m

Total assets £9.6m

Financial history

Revenue by accounting period

3 periods available · ▲ growth ▼ decline

Dec 2023
Not available
Dec 2024
£15.7m
Dec 2025
£18.3m▲ +16.4%
Period endRevenueGrowthProfit before taxEmployeesNet assets
31 Dec 2025£18.3m▲ +16.4%-£223k8-£4.3m
31 Dec 2024£15.7m—-£4.8m14-£4.0m
31 Dec 2023————-£71k

Latest available figures

Period ending 31 Dec 2025. “Not available” means the figure is not in the accounts we hold. We do not estimate missing figures.

Profit & loss

Revenue
£18.3m
Gross profit
£7.3m
Operating profit
£558k
Profit before tax
-£223k
Profit after tax
-£221k

Balance sheet

Total assets
£9.6m
Cash
£1.9m
Total liabilities
£13.9m
Net assets
-£4.3m
Revenue per employee
£2.3m

Similar companies

CompanyRevenueGrowth
Harlette Capital Limited
08565376
£100.0m– 0.0%
Usp Steels Limited
10437761
£99.2m▲ +2.7%
Pickstock Foods Ltd
11412792
£97.3m▲ +18.0%
Crescent Pharma Limited
04750933
£96.5m▼ -8.4%
B.H.C. Limited
NI029649
£96.0m▼ -31.0%

Other manufacturing companies in South East

CompanyRevenueGrowth
Bamford Bus Company Limited
12214576
£455.1m▲ +76.6%
Vine Meats Ltd
12024012
£184.1m▲ +46.5%
Ahmad Tea (UK) Limited
08807852
£139.8m▲ +27.2%
Hunt Forest Group Limited
11523682
£126.1m▲ +8.2%
Optigene Limited
06465874
£120.1m—